2024-11-20 02:21:07
Galimedix Accelerating Development of Its Next-Generation Oral Anti-Amyloid Beta Drug GAL-201 for Alzheimer's Disease
Health/ 2023-07-22
Galimedix Accelerating Development of It...

Following recent FDA approval of Biogen\'s Alzheimer antibody drug ADUHELM (TM),targeting oligomers of amyloid beta,Galimedix aims for first...

Totient, a Viva Biotech Portfolio Company, has been Acquired by AbSci
Corporate/ 2023-07-23
Totient, a Viva Biotech Portfolio Compan...

SHANGHAI,June 16,2021-- Viva Biotech (01873.HK) declared today that Totient,one of its portfolio companies,has been acquired by AbSci,a synt...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release